Source:http://linkedlifedata.com/resource/pubmed/id/14524736
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
21
|
pubmed:dateCreated |
2003-10-3
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0012-6667
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
63
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2325
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading | |
pubmed:year |
2003
|
pubmed:articleTitle |
Oral fludarabine: a viewpoint by Bruce D. Cheson.
|
pubmed:affiliation |
Lombardi Cancer Center, Georgetown University, Washington, DC, USA.
|
pubmed:publicationType |
Journal Article
|